BioWorld

April 11, 2011

Parkinson's Update: Disease Pipeline Running the Gamut

There were roughly 40 million Americans over the age of 65 in 2010, but as the baby boomer generation continues to reach the monumental age, the number of Americans in that class is expected to increase to 70 million in 2030. Read More

A Mega-Merger About-Face as Industry Retools R&D Strategy

Money Raised Year to Date

Money Raised By Biotech in 2011

Week in Review

Week in Washington

Word on the Street

Top 10 Bio/Pharma Deals This Year

Collaborations Between Biotech And Pharmaceutical Companies: Jan. 1 - Apr. 8, 2011

Manufacturing, Marketing And Distribution Agreements Between Biotech And Pharmaceutical Companies: Jan. 1 - Apr. 8, 2011

Biotech – Big Pharma Collaborations: Modified And Terminated Agreements, Jan. 1 - Apr. 8, 2011

Stock Gainers and Losers For The Week

BioWorld Stock Report For Public Biotechnology Companies

No Abstract Read More

Today's news in brief

BioWorld

BioWorld briefs for June 5, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...

Janssen Pharmaceutica reports new TMEM175 activators

BioWorld Science

Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...